Successful implantation of cardiac defibrillators without induction of ventricular fibrillation using upper limit of vulnerability testing

Journal of Interventional Cardiac Electrophysiology

Volumn 8, Issue 1, 2003, Pages 71-75

  Green, Ulrika Birgersdotter ^a,b   Garg, Ashok ^a   Al Kandari, Fawzia ^a   Ungab, GilAnthony ^a   Tone, Linda ^a   Feld, Gregory K ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b NONE   (United States)

Author keywords

Defibrillation threshold (DFT); Implantable cardioverter defibrillator (ICD); Upper limit of vulnerability (ULV)

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DEFIBRILLATOR; ENERGY; FEMALE; FOLLOW UP; HEART VENTRICLE FIBRILLATION; HUMAN; INTERMETHOD COMPARISON; MALE; MEASUREMENT; PRIORITY JOURNAL; SAFETY;

AGED; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; FEMALE; FOLLOW-UP STUDIES; HEART CONDUCTION SYSTEM; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; STROKE VOLUME; SURVIVAL ANALYSIS; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME; VENTRICULAR FIBRILLATION;

EID: 0037298990     PISSN: 1383875X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022304417889     Document Type: Article

References (13)

1. Zipes DP, Roberts D. Results of the international study of implantable pacemaker cardioverter-defibrillator: A comparison of epicardial and endocardial lead systems. Circulation 1995;92:59-65.
2. Moss AJ, Hall WJ, Cannom DS et al. improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Eng J Med 1996;335:1933-1940.
3. The Anti-arrhythmic versus Implantable Defibrillators (AVID) Investigators. A comparison of anti-arrhythmic drug therapy with implantable defibrillators in patients resuscitated from near fatal ventricular arrhythmias. N Eng J Med 1997;337:1576-1583.
4. Stix G, Hirschl M, Vokovich T et al. Myocardial cell damage after repeated ICD therapies demonstrated by circulating cardiac specific proteins. PACE 1998;21:910.
5. Runsio M, Kallner A, Kallner G, Rosenqvist M, Bergfeldt L. Myocardial injury after electrical therapy for cardiac arrhythmias assessed by Troponin-T release. Am J Cardiol 1997;79:1241-1244.
6. Chen PS, Shibata N, Dixon EG et al. Comparison of the defibrillation threshold and the upper limit of vulnerability. Circulation 1986;73:1022-1028.
7. Chen PS, Feld G, Kriett JM et al. Relation between upper limit of vulnerability and defibrillation threshold in humans. Circulation 1993;88:186-192.
8. Hwang C, Swerdlow C, Kass R et al. Upper limit of vulnerability reliability predicts the defibrillation threshold in humans. Circulation 1994;90:2308-2314.
9. Green UB, Undesser K, Fujimura O et al. Correlation of acute and chronic defibrillation threshold with upper limit of vulnerability determined in normal sinus rhythm. J Interven Card Electrophysiol 1999;3:155-161.
10. Birgersdotter-Green U, Mollerus M, Fujimura O, Feld GK. Defibrillation efficacy with ICD first shock energy programmed at ULV plus five joules using the EndoTak transvenous lead system: Comparison of results at implant and during long-term follow-up. Pacing Clin Electrophysiol 1997;20:1223.
11. Swerdlow CD. Implantation of cardioverter defibrillators without induction of ventricular fibrillation. Circulation 2001;103:2159-2164.
12. Swerdlow CD, Martin et al. The zone of vulnerability to T-wave shocks in humans. J Cardiovasc Electrophysiol 1997;8:145-154.
13. Glickson M, Luria D, Friedman PA et al. Are routine arrhythmia inductions necessary in patients with pectoral implantable cardioverter defibrillators? J Cardiovasc Electrophysiol 2000;11:127-135.